Ileocolonic-Targeted JAK Inhibitor: A Safer and More Effective Treatment for Inflammatory Bowel Disease.
Yadav V, House A, Matiz S, McCoubrey LE, Bettano KA, Bhave L, Wang M, Fan P, Zhou S, Woodhouse JD, Poimenidou E, Dou L, Basit AW, Moy LY, Saklatvala R, Hegde LG, Yu H.
Yadav V, et al. Among authors: bettano ka.
Pharmaceutics. 2022 Nov 5;14(11):2385. doi: 10.3390/pharmaceutics14112385.
Pharmaceutics. 2022.
PMID: 36365202
Free PMC article.